111 related articles for article (PubMed ID: 11862349)
1. Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats.
Barr AM; Zis AP; Phillips AG
Psychopharmacology (Berl); 2002 Jan; 159(2):196-202. PubMed ID: 11862349
[TBL] [Abstract][Full Text] [Related]
2. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
Zhornitsky S; Potvin S; Stip E; Rompré PP
Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
Vacca G; Ahn S; Phillips AG
Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
[TBL] [Abstract][Full Text] [Related]
4. Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats.
Todtenkopf MS; O'Neill KS; Kriksciukaite K; Turncliff RZ; Dean RL; Ostrovsky-Day I; Deaver DR
Addict Biol; 2009 Sep; 14(4):408-18. PubMed ID: 19489752
[TBL] [Abstract][Full Text] [Related]
5. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.
Cryan JF; Hoyer D; Markou A
Biol Psychiatry; 2003 Jul; 54(1):49-58. PubMed ID: 12842308
[TBL] [Abstract][Full Text] [Related]
6. Decreased reward during acute alcohol withdrawal in rats selectively bred for low alcohol drinking.
Chester JA; Rausch EJ; June HL; Froehlich JC
Alcohol; 2006 Apr; 38(3):165-72. PubMed ID: 16905442
[TBL] [Abstract][Full Text] [Related]
7. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
Schwabe K; Koch M
Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
Lin D; Koob GF; Markou A
Psychopharmacology (Berl); 1999 Aug; 145(3):283-94. PubMed ID: 10494577
[TBL] [Abstract][Full Text] [Related]
9. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
Paterson NE; Balfour DJ; Markou A
Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats.
Paterson NE; Myers C; Markou A
Psychopharmacology (Berl); 2000 Nov; 152(4):440-6. PubMed ID: 11140337
[TBL] [Abstract][Full Text] [Related]
11. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
Liu J; Schulteis G
Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
[TBL] [Abstract][Full Text] [Related]
12. The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats.
Prins J; Kenny PJ; Doomernik I; Schreiber R; Olivier B; Mechiel Korte S
Eur J Pharmacol; 2012 Oct; 693(1-3):51-6. PubMed ID: 23010469
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement.
Barr AM; Phillips AG
Psychopharmacology (Berl); 1999 Jan; 141(1):99-106. PubMed ID: 9952071
[TBL] [Abstract][Full Text] [Related]
14. Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine.
Peleg-Raibstein D; Sydekum E; Feldon J
Int J Neuropsychopharmacol; 2006 Dec; 9(6):737-49. PubMed ID: 16448582
[TBL] [Abstract][Full Text] [Related]
15. Effects of withdrawal from an escalating dose schedule of d-amphetamine on sexual behavior in the male rat.
Barr AM; Fiorino DF; Phillips AG
Pharmacol Biochem Behav; 1999 Nov; 64(3):597-604. PubMed ID: 10548277
[TBL] [Abstract][Full Text] [Related]
16. Neural substrates of psychostimulant withdrawal-induced anhedonia.
D'Souza MS; Markou A
Curr Top Behav Neurosci; 2010; 3():119-78. PubMed ID: 21161752
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of 5-HT2A receptor mRNA expression following withdrawal from a chronic escalating dose regimen of D-amphetamine.
Horner KA; Gilbert YE; Noble ES
Brain Res; 2011 May; 1390():10-20. PubMed ID: 21420940
[TBL] [Abstract][Full Text] [Related]
18. Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm.
Mavrikaki M; Nomikos GG; Panagis G
Eur Neuropsychopharmacol; 2009 Mar; 19(3):205-14. PubMed ID: 19110403
[TBL] [Abstract][Full Text] [Related]
19. Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects.
Borowski TB; Kokkinidis L
Pharmacol Biochem Behav; 1992 Sep; 43(1):1-15. PubMed ID: 1409792
[TBL] [Abstract][Full Text] [Related]
20. Amphetamine withdrawal does not produce a depressive-like state in rats as measured by three behavioral tests.
Russig H; Pezze MA; Nanz-Bahr NI; Pryce CR; Feldon J; Murphy CA
Behav Pharmacol; 2003 Feb; 14(1):1-18. PubMed ID: 12576877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
